Literature DB >> 9705326

Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells.

K Subbaramaiah1, W J Chung, P Michaluart, N Telang, T Tanabe, H Inoue, M Jang, J M Pezzuto, A J Dannenberg.   

Abstract

We determined whether resveratrol, a phenolic antioxidant found in grapes and other food products, inhibited phorbol ester (PMA)-mediated induction of COX-2 in human mammary and oral epithelial cells. Treatment of cells with PMA induces COX-2 and causes a marked increase in the production of prostaglandin E2. These effects were inhibited by resveratrol. Resveratrol suppressed PMA-mediated increases in COX-2 mRNA and protein. Nuclear run-offs revealed increased rates of COX-2 transcription after treatment with PMA, an effect that was inhibited by resveratrol. PMA caused about a 6-fold increase in COX-2 promoter activity, which was suppressed by resveratrol. Transient transfections utilizing COX-2 promoter deletion constructs and COX-2 promoter constructs, in which specific enhancer elements were mutagenized, indicated that the effects of PMA and resveratrol were mediated via a cyclic AMP response element. Resveratrol inhibited PMA-mediated activation of protein kinase C. Overexpressing protein kinase C-alpha, ERK1, and c-Jun led to 4.7-, 5.1-, and 4-fold increases in COX-2 promoter activity, respectively. These effects also were inhibited by resveratrol. Resveratrol blocked PMA-dependent activation of AP-1-mediated gene expression. In addition to the above effects on gene expression, we found that resveratrol also directly inhibited the activity of COX-2. These data are likely to be important for understanding the anti-cancer and anti-inflammatory properties of resveratrol.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9705326     DOI: 10.1074/jbc.273.34.21875

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  105 in total

1.  Pleiotropic mechanisms facilitated by resveratrol and its metabolites.

Authors:  Barbara Calamini; Kiira Ratia; Michael G Malkowski; Muriel Cuendet; John M Pezzuto; Bernard D Santarsiero; Andrew D Mesecar
Journal:  Biochem J       Date:  2010-07-15       Impact factor: 3.857

2.  Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity.

Authors:  W D Johnson; R L Morrissey; A L Usborne; I Kapetanovic; J A Crowell; M Muzzio; D L McCormick
Journal:  Food Chem Toxicol       Date:  2011-09-10       Impact factor: 6.023

3.  Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets.

Authors:  Ajaikumar B Kunnumakkara; Bokyung Sung; Jayaraj Ravindran; Parmeswaran Diagaradjane; Amit Deorukhkar; Sanjit Dey; Cemile Koca; Zhimin Tong; Juri G Gelovani; Sushovan Guha; Sunil Krishnan; Bharat B Aggarwal
Journal:  Int J Cancer       Date:  2011-11-09       Impact factor: 7.396

4.  Transcription factors in the cellular signaling network as prime targets of chemopreventive phytochemicals.

Authors:  Young-Joon Surh
Journal:  Cancer Res Treat       Date:  2004-10-30       Impact factor: 4.679

Review 5.  Resveratrol biosynthesis: plant metabolic engineering for nutritional improvement of food.

Authors:  Giovanna Giovinazzo; Ilaria Ingrosso; Annalisa Paradiso; Laura De Gara; Angelo Santino
Journal:  Plant Foods Hum Nutr       Date:  2012-09       Impact factor: 3.921

Review 6.  The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.

Authors:  Ercole Cavalieri; Eleanor Rogan
Journal:  Mol Aspects Med       Date:  2013-08-30

Review 7.  Cyclooxygenases and lipoxygenases in cancer.

Authors:  Claus Schneider; Ambra Pozzi
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

8.  Effects of resveratrol in inflammatory arthritis.

Authors:  N Elmali; O Baysal; A Harma; I Esenkaya; B Mizrak
Journal:  Inflammation       Date:  2007-04       Impact factor: 4.092

9.  Association between pterostilbene and quercetin inhibits metastatic activity of B16 melanoma.

Authors:  Paula Ferrer; Miguel Asensi; Ramón Segarra; Angel Ortega; María Benlloch; Elena Obrador; María T Varea; Gregorio Asensio; Leonardo Jordá; José M Estrela
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

10.  Oncogenicity evaluation of resveratrol in p53(+/-) (p53 knockout) mice.

Authors:  T L Horn; M J Cwik; R L Morrissey; I Kapetanovic; J A Crowell; T D Booth; D L McCormick
Journal:  Food Chem Toxicol       Date:  2006-08-08       Impact factor: 6.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.